课题基金 / 基金详情

项目摘要

项目成果

Caleb B. Bell的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The goal of this proposal is to further develop our magneto-endosymbiont (ME) technology for in vivo single cell MRI detection (Phase 1) and functional reporting (Phase 2) thus creating a robust translational tool for cell based research. MEs were derived from magnetic bacteria creating a living contrast agent that enables in vivo cell tracking. MRI is a highly translatable technique for visualizing implanted cells because it is non- invasive and provides extremely high anatomical resolution. MEs are a unique contrast agent because they have a large genetic capacity that can be leveraged to encode functional reporters, in vivo. The effectiveness of MEs for single cell tracking will be experimentally assessed in a metastatic brain cancer model, that we have previously used to demonstrate single cell MRI tracking with superparamagnetic iron oxide particles. Tools that provide insight into detailed cellular events at the single cell level in situ will advance oncology research, regenerative medicine research, personalized diagnostics and the clinical realization of cell therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pre-clinical quantitation of ovarian cancer tumor burden using Magnetic Particle Imaging and non-dilutive cell labeling
Pre-clinical quantitation of ovarian cancer tumor burden using Magnetic Particle Imaging and non-dilutive cell labeling
Tracking cardiac engraftment and viability of MiPSC by MRI
  • 批准号:
    9142123
  • 项目类别:
  • 资助金额:
    $98.34万
  • 财政年份:
    2014
  • 负责人:
    Caleb B. Bell
  • 依托单位:
海外基金